GoldenGolden
Immunochina Pharmaceuticals

Immunochina Pharmaceuticals

Help us improve this page by adding information.
Visit our Writing Guide or this topic page for additional help.

Timeline

January 2019
Immunochina Pharmaceuticals raises a $20,400,000 series C round from China Resources Innovative Equity Investment Fund, Peter Thiel, Qingzhe Capital, Sherpa Capital, Sherpa Venture Capital and Shougang Fund.

Funding rounds

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.